TRIM21‑a potential biomarker for the prognosis of thyroid cancer

Exp Ther Med. 2022 Nov 9;24(6):761. doi: 10.3892/etm.2022.11697. eCollection 2022 Dec.

Abstract

Thyroid cancer (THCA) is one of the commonest malignancies associated with increased recurrence. Therefore, identifying the putative molecular markers and therapeutic targets to improve the treatment of THCA is essential. The present study analyzed the potential role of tripartite motif-containing 21 (TRIM21), a member of the TRIM family belonging to the subfamily of E3 ubiquitin ligases, in the progression of THCA. Using bioinformatics analysis and immunohistochemistry of THCA tissues, it was observed that TRIM21 is overexpressed in THCA tissues. The present study also found that TRIM21 is associated with lymph node metastasis and high-risk recurrence of THCA. Furthermore, it identified a promotional role of TRIM21 in THCA cell migration and invasion. In addition, the present study analyzed TRIM21-enriched pathways and co-expressed genes in THCA. The present study suggested that TRIM21 may serve as a potential biomarker for THCA prognosis.

Keywords: bioinformatical analysis; clinicopathologic features; migration and invasion; thyroid cancer; tripartite motif-containing 21.

Grants and funding

Funding: The present study was supported by the Science and Technology Project of Shandong Society of Geriatrics (grant no. LKJGG2021W069), and the Medical and Health Science project of Shandong Province (grant no. 202104010413).